Are racial differences in obesity and insulin resistance related to aggressive breast cancer?

Authors:

Abstract
1568 Background: Black women are more likely to die of breast cancer and have more aggressive type cancers than white women. Black women are also more likely to have obesity and insulin resistance than white women. Insulin resistance has been associated with faster tumor growth in mouse models of breast cancer, but has not been studied as a potential mediator of racial disparities in women with breast cancer. We hypothesized that black women would have more aggressive breast cancer at presentation and this would be associated with obesity and insulin resistance. Methods: We recruited 281 (80% white, 20% black) women with a new primary breast cancer and measured pre-operative fasting blood glucose and insulin, BMI, waist circumference (WC), Nottingham prognostic index (NPI). We classified aggressive breast cancer as a NPI > 4.4. We calculated HOMA-IR (HOMA) scores and classified insulin resistance a HOMA > 2.8, the upper quartile of insulin resistance in the US population. Patients self-identified race. Results: Of 281 women with new breast cancer, average age was 58 years (SD = 12.5). 181 (64%) were stage I; 89 (32%) stage II; 11 (4%) stage III at time of diagnosis. Seventeen percent of cancers had an NPI > 4.4. There was no racial difference in stage or aggressive breast cancer: 22% of blacks vs. 16% of whites (p = 0.3) had cancers with NPI > 4.4. Eight percent of women were insulin resistant: 11% blacks vs. 7% whites (p = 0.4). There were also racial differences in BMI (32.3 in B vs. 26.0 in W; p < .0001), WC (110cm in B vs 94cm in W, p < 0.001), HOMA score (1.7 in B vs.1.2 vs W; p = 0.002), NPI score (4.0 in B vs. 3.6 in W, p = 0.01) and triple negative breast cancer (15% in B vs 6% in W, p = 0.04). HOMA score was positively associated with NPI score (r = 0.18; p = 0.02). HOMA_IR partially mediates the effect of black race with more aggressive cancer (β = 0.07; 95%CI: 0.02-0.15). Conclusions: Among women with newly diagnosed breast cancer, insulin resistance partially mediates the relationship between black race with more aggressive cancer suggesting that hyperinsulinemia may promote breast cancer progression and contribute to racial disparities in breast cancer survival.